The angiogenic switch of HCC is under the control of variety of angiogenic growth factors and inhibitors, including VEGF, angiopoietins, basic fibroblast growth factor (bFGF), TGF-α, and IGF-II. Here, FGF2 is linked to hepatocellular carcinoma.